Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- Research to Practice
- 1.00 Participation
$0.00
Dr. Trevor Royce from the UNC Lineberger Department of Radiation Oncology will describe relevant updates in radiation oncology for health care providers throughout the state of North Carolina. With a focus on bladder cancer—highlights will include updates on techniques and indications for radiotherapy, toxicity monitoring, recent research, and other issues.
- Research to Practice
- 1.00 Participation
$0.00
Dr. Michael Lee from the UNC Lineberger Gastrointestinal Oncology group will describe relevant updates in systemic therapy for gastrointestinal cancers for health care providers throughout the state of North Carolina.
- Research to Practice
- 1.00 Participation
$0.00
Young Whang, MD, from the UNC Lineberger Genitourinary Oncology group will describe relevant updates in systemic therapy for prostate cancers for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
- Research to Practice
- 1.00 Participation
$0.00
Dr. Siddharth Sheth from the UNC Lineberger Head and Neck Oncology group will describe relevant updates in systemic therapy for head and neck cancers for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
- Research to Practice
- 1.00 Participation
$0.00
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma. For rel/ref DLBCL, polatuzumab vedotin in combination with bendamustine and rituximab as well as tafasitamab plus lenalidomide have been approved in recent years. We will review the data and outcomes.
- Research to Practice
- 1.00 Participation
$0.00
Oral chemotherapy is becoming increasingly common in treatment of various malignancies. Although oral oncolytics are extremely beneficial for patients, they also present unique challenges for patients and providers alike. Implementing oral chemotherapy often requires a multidisciplinary approach. This lecture discusses several considerations for oral chemotherapy such as prescribing, patient education, adherence, medication access, cost and insurance authorization, monitoring, supportive care, and more. We will walk through a patient case to highlight practical suggestions for successful implementation of oral chemotherapy for patients.
- Research to Practice
- 1.00 Participation
$0.00
Arthur Blackstock, Jr., MD, will discuss protons entering the state, the expanded use of Stereotactic Body Radiation Therapy (SBRT), and perhaps review the impact of PSMA imaging in Radiation Oncology.
- Research to Practice
- 1.00 Participation
$0.00
Dr. Joshua Zeidner will discuss updates in the diagnostic testing and prognostic subclassifications of AML which drive therapeutic decisions. This presentation will highlight perceived paradigm shifts for AML and older adults.
- Research to Practice
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Ashley Weiner, MD, PhD, presents on the role of radiotherapy for small-cell lung cancer. She provides overview of radiation oncology, and a walk through a patient's pathway from initial consultation with a radiation oncologist to treatment and follow-up. Finally, she reviews the indications for, logistics of, and side effects of radiation for the treatment of small cell lung cancer (limited and extensive stage).
- Research to Practice
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.